Lepu Biopharma Co., Ltd.
Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on developing oncology therapeutics with a pipeline designed with a range of oncology products in China. The company develops oncology drug candidates, including antibody-drug conjugates (ADC…
Biotechnology
CN, Shanghai [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | 0.00 | 0.75 | 0.75 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | -100.00 | -1.46 | 0.00 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Book Value | 100.00 | 0.54 | 0.00 | |
| Cash | 100.00 | 0.30 | 0.00 | |
| Capex | -100.00 | -0.01 | 0.00 | |
| Free Cash Flow | -100.00 | -0.13 | 0.00 | |
| Revenue | 100.00 | 0.05 | 0.00 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q2 | Q4 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -100.00 | -0.02 | 0.00 | |
| Operating Margin | -100.00 | -3.54 | 0.00 | |
| ROA | n.A. | 0.05 | n.A. | |
| ROE | n.A. | 0.14 | n.A. | |
| ROIC | n.A. | -0.54 | n.A. | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of 2157.HK is permitted for members.
5
Growth
The "Growth Entry" for the Focus of 2157.HK is permitted for members.
6
Leverage & Liquidity